Pre-treatment Circulating Tumor Cell Associated White Blood Cell Clusters Independently Predict Poor Survival in Patients with Extensive-disease Small Cell Lung Cancer
Ideal biomarkers should be more specific for survival prediction in patients with different disease stages. Pre-treatment CTC-WBC clusters can independently predict inferior OS in ED-SCLC but not LD-SCLC.
Authors
- Zhanliang Ren
- Minghang Zhang
- Peter Ping Lin (ORCID: https://orcid.org/0000-0002-6869-9490)
- Hongxia Li (ORCID: https://orcid.org/0000-0002-1440-1345)
- Baohua Lu (ORCID: https://orcid.org/0000-0001-7715-9421)
- Hongmei Zhang
- Ying Wang (ORCID: https://orcid.org/0000-0002-1819-294X)
- Cen Chen (ORCID: https://orcid.org/0000-0003-1389-0148)
- Ming‐Ming Hu (ORCID: https://orcid.org/0000-0001-9667-7662)
- Shaofa Xu (ORCID: https://orcid.org/0000-0003-2081-6608)
- Yanxia Liu (ORCID: https://orcid.org/0000-0003-1479-4043)
- Yuan Gao (ORCID: https://orcid.org/0000-0002-3129-211X)
- Tongmei Zhang (ORCID: https://orcid.org/0000-0003-4271-3773)
Institutions
- Capital Medical University (CN)
- Beijing Chest Hospital (CN)
- Affiliated Hospital of Shaanxi University of Chinese Medicine (CN)
- Shaanxi University of Chinese Medicine (CN)
- Cytel (United States) (US)
Publication Details
- Journal
- Biomarker Insights
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1177/11772719251338620
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Municipal Science and Technology Commission